Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling

被引:958
作者
Takagi, J
Petre, BM
Walz, T
Springer, TA [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Ctr Blood Res, Dept Pediat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0092-8674(02)00935-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
How ligand binding alters integrin conformation in outside-in signaling, and how inside-out signals alter integrin affinity for ligand, have been mysterious. We address this with electron microscopy, physicochemical measurements, mutational introduction of disulfides, and ligand binding to alphaVbeta3 and alphaIIbbeta3 integrins. We show that a highly bent integrin conformation is physiological and has low affinity for biological ligands. Addition of a high affinity ligand mimetic peptide or Mn2+ results in a switch blade-like opening to an extended structure. An outward swing of the hybrid domain at its junction with the I-like domain shows conformational change within the headpiece that is linked to ligand binding. Breakage of a C-terminal clasp between the alpha and beta subunits enhances Mn2+ induced unbending and ligand binding.
引用
收藏
页码:599 / 611
页数:13
相关论文
共 46 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   Are changes in integrin affinity and conformation overemphasized? [J].
Bazzoni, G ;
Hemler, ME .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (01) :30-34
[3]   Divalent cations and ligands induce conformational changes that are highly divergent among β1 integrins [J].
Bazzoni, G ;
Ma, L ;
Blue, ML ;
Hemler, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6670-6678
[4]  
Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO
[5]  
2-D
[6]   Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation [J].
Beglova, N ;
Blacklow, SC ;
Takagi, J ;
Springer, TA .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) :282-287
[7]   Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated [J].
Billheimer, JT ;
Dicker, IB ;
Wynn, R ;
Bradley, JD ;
Cromley, DA ;
Godonis, HE ;
Grimminger, LC ;
He, BK ;
Kieras, CJ ;
Pedicord, DL ;
Spitz, SM ;
Thomas, BE ;
Zolotarjova, NI ;
Gorko, MA ;
Hollis, GF ;
Daly, RN ;
Stern, AM ;
Seiffert, D .
BLOOD, 2002, 99 (10) :3540-3546
[8]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[9]  
Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427
[10]   N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists [J].
Dechantsreiter, MA ;
Planker, E ;
Mathä, B ;
Lohof, E ;
Hölzemann, G ;
Jonczyk, A ;
Goodman, SL ;
Kessler, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (16) :3033-3040